Metabolic health monitoring platform Vively has raised $1.6 million in a Seed round as it rolls out its Continuous Glucose Monitoring (CGM) program to tackle pre-diabetes. The round was led by Archangel Ventures with support from Bupa Ventures, the VC arm of not-for-profit private health insurer Bupa, and others. Archangel previously led 2022’s $1.5 million… Read more »
Life sciences accelerator MTPConnect has teamed up with health tech industry giants CSL and Roche Diagnostics to launch a new program backing startups tackling cardiovascular disease (CVD) and diabetes. The $28.5 million Targeted Translation Research Accelerator (TTRA) is backed by the federal government’s $22 billion Medical Research Future Fund and will look to back promising drugs… Read more »
CSIRO has unveiled a new AI-powered eye screening solution that enables general practitioners (GPs) to test diabetic patients for diabetic retinopathy.
PredictBGL is an insulin dosage app for people for Type 1 diabetes helping users track their food, exercise and predict changes in blood sugar levels.
Daily startup news and insights, delivered to your inbox.
